When and Why to Aliquot
The 30-Day Problem
Reconstituted peptides stored in BAC water at 2-8°C are stable for approximately 28-30 days. A 30 mg vial used at 1 mg/day would take 30 days to exhaust, right at the stability limit. A 30 mg vial used at 500 mcg/day (0.5 mg/day) would take 60 days - double the safe refrigeration window. Aliquoting solves this by freezing portions that are only thawed as needed.Contamination Prevention
Each needle insertion carries a small contamination risk even with proper alcohol swabbing. A 30-day vial receiving daily punctures accumulates 30 contamination events. Aliquoting once and freezing individual doses eliminates ongoing puncture risk.Dosing Precision
Pre-measured aliquots in individual syringes eliminate calculation errors at injection time, each aliquot is the exact dose, ready to inject after thawing.Supplies Needed
- Peptide vial (reconstituted at known concentration) - Sufficient insulin syringes (one per aliquot dose) - Syringe caps / needle caps (to seal pre-filled syringes) - Alcohol swabs - Permanent marker (for labeling) - Freezer-safe container or bag - Label tape or sticky labels
Optional: Small crimp-top glass vials (2 mL, sterile, with rubber septa) for aliquoting into individual mini-vials instead of syringes.
Calculate your Vial Aliquoting Guide dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Step-by-Step Aliquoting Process
Step 1: Reconstitute at Aliquot-Friendly Concentration
Plan your reconstitution concentration with aliquoting in mind. For a 30 mg vial with a 1 mg/day dose: add 30 mL BAC water = 1 mg/mL solution. Each 1 mL aliquot (100 units on U-100 syringe) = exactly 1 mg. Simple math reduces errors.Step 2: Work Quickly on a Clean Surface
Swab all vial tops with fresh alcohol swabs. Work in a clean environment, kitchen counter away from air vents, not near fans. Have all syringes pre-laid out before starting.Step 3: Draw Each Aliquot Precisely
Using a fresh insulin syringe for each aliquot, draw the target dose volume. Tap to remove air bubbles. Be consistent, the same technique, same angle, same draw speed for each syringe.Step 4: Cap Each Syringe Immediately
Replace the needle cap on each filled syringe immediately after drawing. Do not recap by re-inserting the needle into the original cap from above, use a one-handed scoop technique to avoid needlestick.Step 5: Label Every Syringe
Each syringe must be labeled before freezing: peptide name, dose (mg or mcg), concentration (mg/mL), reconstitution date, aliquot date. Label directly on the syringe barrel with a permanent marker or use a label wrap.Step 6: Freeze Upright or Horizontal in a Container
Place capped syringes into a small container (silicone ice cube tray, rigid storage box) so they cannot roll or the plunger cannot depress. Store at -20°C (standard freezer). Do not use frost-free freezers, freeze-thaw cycles from auto-defrost degrade peptides.Step 7: Thaw Before Use
Remove one aliquot syringe from freezer. Allow to reach room temperature naturally (15-30 min) or hold in palm. Do NOT microwave. Once thawed to room temperature, inject promptly, do not refreeze a thawed aliquot.Frozen Aliquot Stability
Most lyophilized" class="wiki-gloss-link">lyophilized peptides reconstituted and frozen as aliquots are stable for 3-6 months at -20°C when freeze-thaw cycles are avoided. Some peptides (BPC-157, TB-500, Epithalon) have community-reported stability beyond 6 months frozen, though formal stability data is limited.
Peptides with Reduced Freeze Stability
Some peptides degrade faster when frozen in solution: GLP-1 analogs (semaglutide, tirzepatide), IGF-1-LR3, and certain fragile peptides may aggregate or degrade in solution at -20°C faster than in powder form. For these, lyophilized storage (powder) with fresh reconstitution per use is preferred.Signs of Degraded Frozen Aliquots
Discard if, after thawing, the solution: appears cloudy or shows particulate, has changed color, or has an unusual odor. Clear, colorless (or slight yellow for some peptides) solution after thawing is a good sign.References
- [1]ICH Q1A(R2). "Stability Testing of New Drug Substances and Products." International Conference on Harmonisation, 2003.
- [2]Wang W. "Instability, stabilization, and formulation of liquid protein pharmaceuticals." International Journal of Pharmaceutics. 1999.